APA
Mullins C. D., Seal B., Seoane-Vazquez E., Sankaranarayanan J., Asche C. V., Jayadevappa R., Lee W. C., Romanus D. K., Wang J., Hay J. W. & Smeeding J. (20100908). Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Chicago
Mullins C Daniel, Seal Brian, Seoane-Vazquez Enrique, Sankaranarayanan Jayashri, Asche Carl V, Jayadevappa Ravishankar, Lee Won Chan, Romanus Dorothy K, Wang Junling, Hay Joel W and Smeeding Jim. 20100908. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Harvard
Mullins C. D., Seal B., Seoane-Vazquez E., Sankaranarayanan J., Asche C. V., Jayadevappa R., Lee W. C., Romanus D. K., Wang J., Hay J. W. and Smeeding J. (20100908). Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
MLA
Mullins C Daniel, Seal Brian, Seoane-Vazquez Enrique, Sankaranarayanan Jayashri, Asche Carl V, Jayadevappa Ravishankar, Lee Won Chan, Romanus Dorothy K, Wang Junling, Hay Joel W and Smeeding Jim. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20100908.